139 related articles for article (PubMed ID: 25304123)
1. Cost-effectiveness of CPAP treatment related to cardiovascular disease in patients with severe OSAS: the Greek experience.
Mermigkis C; Bouloukaki I; Schiza SE
Sleep Breath; 2015 May; 19(2):737-9. PubMed ID: 25304123
[No Abstract] [Full Text] [Related]
2. A health-economic analysis of diagnosis and treatment of obstructive sleep apnea with continuous positive airway pressure in relation to cardiovascular disease. The Greek experience.
Trakada G; Economou NT; Nena E; Trakada A; Zarogoulidis P; Steiropoulos P
Sleep Breath; 2015 May; 19(2):467-72. PubMed ID: 25138389
[TBL] [Abstract][Full Text] [Related]
3. The economic impact of obstructive sleep apnea.
Tarasiuk A; Reuveni H
Curr Opin Pulm Med; 2013 Nov; 19(6):639-44. PubMed ID: 24060978
[TBL] [Abstract][Full Text] [Related]
4. Cost-effectiveness of using continuous positive airway pressure in the treatment of severe obstructive sleep apnoea/hypopnoea syndrome in the UK.
Guest JF; Helter MT; Morga A; Stradling JR
Thorax; 2008 Oct; 63(10):860-5. PubMed ID: 18408048
[TBL] [Abstract][Full Text] [Related]
5. Cost-effectiveness of continuous positive airway pressure therapy in patients with obstructive sleep apnea-hypopnea in British Columbia.
Tan MC; Ayas NT; Mulgrew A; Cortes L; FitzGerald JM; Fleetham JA; Schulzer M; Ryan CF; Ghaeli R; Cooper P; Marra CA
Can Respir J; 2008 Apr; 15(3):159-65. PubMed ID: 18437259
[TBL] [Abstract][Full Text] [Related]
6. Factors affecting the decision to be treated with continuous positive airway pressure for obstructive sleep apnea syndrome.
Tzischinsky O; Shahrabani S; Peled R
Isr Med Assoc J; 2011 Jul; 13(7):413-9. PubMed ID: 21838183
[TBL] [Abstract][Full Text] [Related]
7. Clinical outcomes and cost-effectiveness of continuous positive airway pressure to manage obstructive sleep apnea in patients with type 2 diabetes in the U.K.
Guest JF; Panca M; Sladkevicius E; Taheri S; Stradling J
Diabetes Care; 2014; 37(5):1263-71. PubMed ID: 24705611
[TBL] [Abstract][Full Text] [Related]
8. An integrated health-economic analysis of diagnostic and therapeutic strategies in the treatment of moderate-to-severe obstructive sleep apnea.
Pietzsch JB; Garner A; Cipriano LE; Linehan JH
Sleep; 2011 Jun; 34(6):695-709. PubMed ID: 21629357
[TBL] [Abstract][Full Text] [Related]
9. COST-EFFECTIVENESS OF TREATMENTS FOR MILD-TO-MODERATE OBSTRUCTIVE SLEEP APNEA IN FRANCE.
Poullié AI; Cognet M; Gauthier A; Clementz M; Druais S; Späth HM; Perrier L; Scemama O; Pichon CR; Harousseau JL
Int J Technol Assess Health Care; 2016 Jan; 32(1-2):37-45. PubMed ID: 26956455
[TBL] [Abstract][Full Text] [Related]
10. Cost-effectiveness of continuous positive airway pressure therapy for obstructive sleep apnea: health care system and societal perspectives.
Streatfeild J; Hillman D; Adams R; Mitchell S; Pezzullo L
Sleep; 2019 Dec; 42(12):. PubMed ID: 31403163
[TBL] [Abstract][Full Text] [Related]
11. Cost-effectiveness of continuous positive airway pressure therapy for moderate to severe obstructive sleep apnea/hypopnea.
Ayas NT; FitzGerald JM; Fleetham JA; White DP; Schulzer M; Ryan CF; Ghaeli R; Mercer GW; Cooper P; Tan MC; Marra CA
Arch Intern Med; 2006 May; 166(9):977-84. PubMed ID: 16682570
[TBL] [Abstract][Full Text] [Related]
12. Association between adherence to continuous positive airway pressure treatment and cost among medicare enrollees.
Chhatre S; Chang YHA; Gooneratne NS; Kuna S; Strollo P; Jayadevappa R
Sleep; 2020 Jan; 43(1):. PubMed ID: 31403696
[TBL] [Abstract][Full Text] [Related]
13. Utilization of healthcare resources in obstructive sleep apnea syndrome: a 5-year follow-up study in men using CPAP.
Albarrak M; Banno K; Sabbagh AA; Delaive K; Walld R; Manfreda J; Kryger MH
Sleep; 2005 Oct; 28(10):1306-11. PubMed ID: 16295216
[TBL] [Abstract][Full Text] [Related]
14. Financial incentive of home continuous positive airway pressure machine use in the inpatient hospital setting.
Smith DF; Spiceland CP; Pringle LC; Mattare KL; Benke JR; Ishman SL
Laryngoscope; 2014 Sep; 124(9):2200-4. PubMed ID: 24448722
[TBL] [Abstract][Full Text] [Related]
15. Continuous positive airway pressure titration for obstructive sleep apnoea: automatic versus manual titration.
McArdle N; Singh B; Murphy M; Gain KR; Maguire C; Mutch S; Hillman DR
Thorax; 2010 Jul; 65(7):606-11. PubMed ID: 20627917
[TBL] [Abstract][Full Text] [Related]
16. Cost-effectiveness of Continuous Positive Airway Pressure Treatment in Moderate-Severe Obstructive Sleep Apnea Syndrome.
Català R; Villoro R; Merino M; Sangenís S; Colomés L; Hernández Flix S; Pérez de Llano LA
Arch Bronconeumol; 2016 Sep; 52(9):461-9. PubMed ID: 26993090
[TBL] [Abstract][Full Text] [Related]
17. Continuous positive airway pressure therapy for obstructive sleep apnea syndrome: do the dollars make sense?
Ayas NT; Marra C
Sleep; 2005 Oct; 28(10):1211-3. PubMed ID: 16295201
[No Abstract] [Full Text] [Related]
18. Reducing the cost of treating obstructive sleep apnea: good news for patients.
Stradling JR
Am J Respir Crit Care Med; 2004 Dec; 170(11):1143-4. PubMed ID: 15563640
[No Abstract] [Full Text] [Related]
19. Role of primary care in the follow-up of patients with obstructive sleep apnoea undergoing CPAP treatment: a randomised controlled trial.
Sánchez-de-la-Torre M; Nadal N; Cortijo A; Masa JF; Duran-Cantolla J; Valls J; Serra S; Sánchez-de-la-Torre A; Gracia M; Ferrer F; Lorente I; Urgeles MC; Alonso T; Fuentes A; Armengol F; Lumbierres M; Vázquez-Polo FJ; Barbé F;
Thorax; 2015 Apr; 70(4):346-52. PubMed ID: 25766689
[TBL] [Abstract][Full Text] [Related]
20. Oral appliance versus continuous positive airway pressure in obstructive sleep apnea syndrome: a 2-year follow-up.
Doff MH; Hoekema A; Wijkstra PJ; van der Hoeven JH; Huddleston Slater JJ; de Bont LG; Stegenga B
Sleep; 2013 Sep; 36(9):1289-96. PubMed ID: 23997361
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
